These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33451073)

  • 1. Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis.
    Busardò FP; Pérez-Acevedo AP; Pacifici R; Mannocchi G; Gottardi M; Papaseit E; Pérez-Mañá C; Martin S; Poyatos L; Pichini S; Farré M
    Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33451073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis.
    Pérez-Acevedo AP; Pacifici R; Mannocchi G; Gottardi M; Poyatos L; Papaseit E; Pérez-Mañá C; Martin S; Busardò FP; Pichini S; Farré M
    Phytother Res; 2021 Mar; 35(3):1646-1657. PubMed ID: 33155722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual.
    Pichini S; Mannocchi G; Gottardi M; Pérez-Acevedo AP; Poyatos L; Papaseit E; Pérez-Mañá C; Farré M; Pacifici R; Busardò FP
    Talanta; 2020 Mar; 209():120537. PubMed ID: 31892011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis.
    Pérez-Acevedo AP; Busardò FP; Pacifici R; Mannocchi G; Gottardi M; Poyatos L; Papaseit E; Pérez-Mañá C; Martin S; Di Trana A; Pichini S; Farré M
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33322849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract.
    Wakshlag JJ; Schwark WS; Deabold KA; Talsma BN; Cital S; Lyubimov A; Iqbal A; Zakharov A
    Front Vet Sci; 2020; 7():505. PubMed ID: 33102539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
    Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R
    J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles.
    Hannon MB; Deabold KA; Talsma BN; Lyubimov A; Iqbal A; Zakharov A; Gamble LJ; Wakshlag JJ
    J Vet Pharmacol Ther; 2020 Sep; 43(5):508-511. PubMed ID: 32735381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry.
    Pacifici R; Marchei E; Salvatore F; Guandalini L; Busardò FP; Pichini S
    Clin Chem Lab Med; 2017 Aug; 55(10):1555-1563. PubMed ID: 28207408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
    Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
    Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair.
    Auwärter V; Wohlfarth A; Traber J; Thieme D; Weinmann W
    Forensic Sci Int; 2010 Mar; 196(1-3):10-3. PubMed ID: 20129747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Action and Pharmacokinetics of Cannabis.
    Chayasirisobhon S
    Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
    Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R
    J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study.
    Pellesi L; Licata M; Verri P; Vandelli D; Palazzoli F; Marchesi F; Cainazzo MM; Pini LA; Guerzoni S
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1427-1436. PubMed ID: 29980818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.
    Hädener M; Vieten S; Weinmann W; Mahler H
    Forensic Sci Int; 2019 Feb; 295():207-212. PubMed ID: 30638755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
    Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
    J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined doses of Δ
    Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.